Immune Design Corporation

116 articles about Immune Design Corporation

• Immune Design Corporation To Report First Quarter 2017 Financial Results & Provide Corporate Update

  5/8/2017

• Immune Design Corporation Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update

  3/8/2017

• Immune Design Corporation To Report Fourth Quarter And Year End 2016 Financial Results And Provide Corporate Update

  3/2/2017

• Immune Design Corporation Receives Orphan Drug Designation For G100 Intratumoral Product Candidate

  2/22/2017

• Immune Design Corporation Provides Update From Two Discovery Platforms: DC-Tropic Zvex Delivering Multiple Tumor Antigens (Conserved And Neo-Antigens) And G100 For Intratumoral Immunotherapy

  12/5/2016

• New Immune Design Corporation Data Highlights Expanded Product Potential Of Zvex® Platform At The 2016 SITC Annual Meeting

  11/11/2016

• Immune Design Corporation Reports Third Quarter 2016 Financial Results And Provides Corporate Update

  11/10/2016

• Immune Design Corporation To Report Third Quarter 2016 Financial Results & Present At Upcoming Investor Conference

  11/2/2016

• Immune Design Corporation Appoints Sergey Yurasov, M.D., Ph.D. As Senior Vice President Of Clinical Development And Chief Medical Officer

  10/4/2016

• Immune Design Corporation Announces Advancement Of First GLAAS-Based Allergy Program Into Clinical Development

  9/28/2016

• Immune Design Corporation Prices Public Offering Of Common Stock

  9/15/2016

• Immune Design Corporation Announces Proposed Public Offering Of Common Stock

  9/15/2016

• Immune Design Corporation Reports Second Quarter 2016 Financial Results And Provides Corporate Update

  8/10/2016

• Immune Design Corporation To Report Second Quarter 2016 Financial Results

  8/2/2016

• Immune Design Corporation Appoints Susan L. Kelley, M.D. To Board Of Directors

  6/16/2016

• ASCO2016: Immune Design Corporation Releases New PFS, OS And TME Data From Trials Of Three Immuno-Oncology Product Candidates

  6/8/2016

• Immune Design Corporation Announces Upcoming Events

  6/1/2016

• Immune Design Corporation To Present At UBS Global Healthcare Conference 2016

  5/17/2016

• Immune Design Corporation Reports First Quarter 2016 Financial Results And Provides Corporate Update

  5/11/2016

• Immune Design Corporation And Gritstone Oncology Announce Clinical Collaboration For Neoantigen Cancer Immunotherapy

  5/9/2016